Additive effects of green tea and coffee on all-cause mortality in patients with type 2 diabetes mellitus: the Fukuoka Diabetes Registry.


Journal

BMJ open diabetes research & care
ISSN: 2052-4897
Titre abrégé: BMJ Open Diabetes Res Care
Pays: England
ID NLM: 101641391

Informations de publication

Date de publication:
10 2020
Historique:
received: 05 02 2020
revised: 03 07 2020
accepted: 13 08 2020
entrez: 22 10 2020
pubmed: 23 10 2020
medline: 22 6 2021
Statut: ppublish

Résumé

The impact of consuming green tea or coffee on mortality in patients with diabetes is controversial. We prospectively investigated the impact of each beverage and their combination on mortality among Japanese patients with type 2 diabetes. In all, 4923 patients (2790 men, 2133 women) with type 2 diabetes (mean age, 66 years) were followed prospectively (median, 5.3 years; follow-up rate, 99.5%). We evaluated the amount of green tea and coffee consumed using self-administered questionnaires. During the follow-up period, 309 participants died. The consumption of green tea, coffee, and a combination of the beverages was associated with reduced all-cause mortality. Multivariable-adjusted hazard ratios (95% CIs) for green tea were as follows: none 1.0 (referent); 0.85 (0.60-1.22) for ≤1 cup/day; 0.73 (0.51-1.03) for 2-3 cups/day; 0.60 (0.42-0.85) for ≥4 cups/day; and P for trend, 0.002. For coffee, they were: none 1.0 (referent); 0.88 (0.66-1.18) for <1 cup/day; 0.81 (0.58-1.13) for 1 cup/day; 0.59 (0.42-0.82) for ≥2 cups/day; P for trend, 0.002. With the combination they were 1.0 (referent) for no consumption of green tea and coffee; 0.49 (0.24-0.99) for 2-3 cups/day of green tea with ≥2 cups/day of coffee; 0.42 (0.20-0.88) for ≥4 cups/day of green tea with 1 cup/day of coffee; and 0.37 (0.18-0.77) for ≥4 cups/day of green tea with ≥2 cups/day of coffee. Higher consumption of green tea and coffee was associated with reduced all-cause mortality: their combined effect appeared to be additive in patients with type 2 diabetes.

Identifiants

pubmed: 33087342
pii: 8/1/e001252
doi: 10.1136/bmjdrc-2020-001252
pmc: PMC7577036
pii:
doi:

Substances chimiques

Coffee 0
Tea 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

JAMA Intern Med. 2018 Aug 1;178(8):1086-1097
pubmed: 29971434
Diabetologia. 2009 May;52(5):810-7
pubmed: 19266179
Am J Clin Nutr. 2017 Oct;106(4):1113-1120
pubmed: 28835365
BMJ. 2017 Nov 22;359:j5024
pubmed: 29167102
Am J Clin Nutr. 2020 Feb 1;111(2):448-458
pubmed: 31891374
Diabetes Care. 2013 Mar;36(3):611-7
pubmed: 23150286
Cochrane Database Syst Rev. 2009 Jul 08;(3):CD005004
pubmed: 19588362
BMJ. 2010 Feb 23;340:c654
pubmed: 20179132
Diabetes Care. 2012 Dec;35(12):2650-64
pubmed: 23100048
Ann Intern Med. 2017 Aug 15;167(4):228-235
pubmed: 28693036
Diabetes Res Clin Pract. 2014 Feb;103(2):137-49
pubmed: 24630390
Front Endocrinol (Lausanne). 2018 Sep 20;9:547
pubmed: 30294299
Med Sci Sports Exerc. 2000 Sep;32(9 Suppl):S498-504
pubmed: 10993420
Am J Epidemiol. 2015 Dec 15;182(12):1010-22
pubmed: 26614599
Diabetes Care. 2019 Jan;42(Suppl 1):S46-S60
pubmed: 30559231
Br J Nutr. 2015 Sep 14;114(5):673-83
pubmed: 26202661
N Engl J Med. 2012 May 17;366(20):1891-904
pubmed: 22591295
Eur J Nutr. 2017 Oct;56(7):2215-2244
pubmed: 28391515
Lancet. 2003 Feb 22;361(9358):703-4
pubmed: 12606201
Diabetologia. 2006 Nov;49(11):2618-26
pubmed: 17019600
Diabetes Care. 2009 Jun;32(6):1043-5
pubmed: 19228865
Stroke. 2013 May;44(5):1369-74
pubmed: 23493733
Diabetes Care. 2019 Jul;42(7):1234-1240
pubmed: 31076414
Molecules. 2016 Jul 28;21(8):
pubmed: 27483219
JAMA. 2006 Mar 8;295(10):1135-41
pubmed: 16522833
Am J Clin Nutr. 2006 Oct;84(4):682-93
pubmed: 17023692
JAMA. 2006 Sep 13;296(10):1255-65
pubmed: 16968850
Public Health Nutr. 2011 Jul;14(7):1200-11
pubmed: 21477414
Eur J Epidemiol. 2016 Dec;31(12):1191-1205
pubmed: 27699514
Am Fam Physician. 2009 Apr 1;79(7):591-4
pubmed: 19378876
Am J Kidney Dis. 2009 Jun;53(6):982-92
pubmed: 19339088
Int J Environ Res Public Health. 2018 Aug 06;15(8):
pubmed: 30082581
Crit Rev Food Sci Nutr. 2018 Apr 13;58(6):924-941
pubmed: 27645804
J Hypertens. 2005 May;23(5):921-8
pubmed: 15834273
Diabet Med. 2011 Oct;28(10):1221-8
pubmed: 21658121
Circulation. 2002 Dec 3;106(23):2935-40
pubmed: 12460875

Auteurs

Yuji Komorita (Y)

Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Division of Internal Medicine, Fukuoka Dental College, Fukuoka, Japan.

Masanori Iwase (M)

Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan iwase@intmed2.med.kyushu-u.ac.jp.
Diabetes Center, Hakujyuji Hospital, Fukuoka, Japan.

Hiroki Fujii (H)

Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Toshiaki Ohkuma (T)

Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Hitoshi Ide (H)

Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Tamaki Jodai-Kitamura (T)

Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Masahito Yoshinari (M)

Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Yutaro Oku (Y)

Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Taiki Higashi (T)

Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Udai Nakamura (U)

Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Takanari Kitazono (T)

Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH